JEREMY LEVIN

The analyst suggested a stoploss at Rs 296.

Buy Biocon Ltd. at a price target of Rs 634.0 and a stoploss at Rs 608 from entry point.

Sell Biocon Ltd. at a price target of Rs 590.0 and a stoploss at Rs 616 from entry point.

Buy Biocon Ltd. at a price target of Rs 682.0 and a stoploss at Rs 658 from entry point.

Buy Biocon Ltd. at a price target of Rs 688.0 and a stoploss at Rs 660 from entry point.

Buy Biocon Ltd. at a price target of Rs 670.0 and a stoploss at Rs 625 from entry point.

Buy Biocon Ltd. at a price target of Rs 658.0 and a stoploss at Rs 634 from entry point.

Buy Biocon Ltd. at a price target of Rs 650.0 and a stoploss at Rs 620 from entry point.

Buy Biocon Ltd. at a price target of Rs 706.0 and a stoploss at Rs 668 from entry point.

Buy Biocon Ltd. at a price target of Rs 660.0 and a stop loss at Rs 630 from the entry point.

Buy Biocon Ltd. at a price target of Rs 625.0 and a stop loss at Rs 594 from entry point.

Buy Biocon Ltd. at a price target of Rs 668.0 and a stop loss at Rs 622 from entry point.

Buy Biocon Ltd. at a price target of Rs 642.0 and a stop loss at Rs 606 from entry point.

Buy Biocon Ltd. at a price target of Rs 641.0 and a stop loss at Rs 620 from entry point.

Buy Biocon at a price target of Rs 380 and a stop loss at Rs 363 from entry point.

Natco Pharma has lost a patent litigation against Israel's Teva Pharmaceutical Industries in the US over multiple sclerosis treatment drug,...